Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-15-009161)

Filing Details

Accession Number:: 0001140361-15-009161
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-26 17:37:46
Reporting Period:: 2015-02-25

Filing Date:: 2015-02-26
Accepted Time:: 2015-02-26 17:37:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1594337	Corium International Inc.	CORI	Pharmaceutical Preparations (2834)	383230774

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1271088	D Peter Staple	C/O Corium International, Inc. 235 Constitution Drive Menlo Park CA 94025	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-02-25	3,600	$6.99	22,378	No	4	P	Indirect	by The Staple Family 2006 Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	by The Staple Family 2006 Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,000	Direct

Footnotes

Represents the aggregate of purchases effected on the same day at different prices.
Represents the weighted average purchase price per share. The shares were purchased at prices ranging from $6.96 to $7.00. Full information regarding the number of shares purchased at each price shall be provided, upon written request, to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.